John is a BBSRC DTP PhD student from Philadelphia, working in collaboration with the Cambridge Early Cancer Institute and AstraZeneca. His research centres on the design of senolytic antibody-drug conjugates (ADCs) for the targeted treatment of respiratory diseases. John holds a BSc in Biochemistry from the University of Leeds, where he received the Royal Society of Biology’s Top Student Award. His previous experience includes research on diagnostic immunoassays, next-generation RNA therapeutics, and antibody mimetics for imaging applications. Outside the lab, John enjoys running and serves as the Social Officer for the Department of Chemical Engineering and Biotechnology (CEB) Graduate Society.